Rostra Therapeutics Ltd
Solution Type
Antimicrobial Compound
Pathogens Addressed
Bacteria, Fungi, Viruses, Yeasts, Parasites
Sectors Served
Human Health
Overview
Rostra Therapeutics is a London-based drug discovery company developing S-MGB (Sequence-selective Minor Groove Binding) molecules that kill bacteria, fungi, parasites, and viruses by binding simultaneously to multiple sites on DNA and RNA. This multi-target mechanism of action is inherently difficult for pathogens to evade through resistance, positioning S-MGBs as a potentially resilient platform for new anti-infective therapeutics.
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.